From: Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy
Drug
N(%)
Adefovir dipivoxil
188 (20.4)
Lamivudine
86 (9.3)
Entecavir
490 (53.1)
Telbivudine
9 (1.0)
Tenofovir
12 (1.3)
Adefovir + Lamivudine
77 (8.3)
Adefovir + Entecavir
43 (4.7)
Adefovir + Telbivudine
17 (1.8)
Entecavir + Tenofovir
1 (0.1)